Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gritstone Bio Inc (NQ: GRTS )

3.170 -0.050 (-1.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 260,283
Open 3.180
Bid (Size) 3.080 (6)
Ask (Size) 3.330 (1)
Prev. Close 3.220
Today's Range 3.140 - 3.280
52wk Range 1.710 - 6.100
Shares Outstanding 83,366,277
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday. 
Via Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
Via Benzinga

Performance

YTD
-9.43%
-9.43%
1 Month
-8.12%
-8.12%
3 Month
-1.55%
-1.55%
6 Month
+27.31%
+27.31%
1 Year
-41.94%
-41.94%

More News

Read More
Gritstone bio Shares Jump After Updated Overall Survival Data From Colorectal Cancer Candidate
Via Benzinga
Gritstone's Cancer Drug Shows Strong Tumor-Specific Responses In Various Settings
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Board Member
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
From Predictive Oncology Inc.
Via Globe NewsWire
Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Block To 100? Plus This Analyst Slashes PT On Estée Lauder By 32%
Via Benzinga
Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update
From Gritstone bio
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Via Benzinga
Gritstone Oncology's Return On Capital Employed Overview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Via Benzinga
Goldman Sachs Is Bearish On Gritstone Bio: 'Avenues For Financing Are Likely Too Modest'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Earnings Outlook For Gritstone Oncology
Via Benzinga
Gritstone Bio's Earnings Outlook
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.